Dana Edwards, UBC’s VP of Patient Access and Strategic Engagement, sat down with Pharmaceutical Commerce to discuss how to keep your engagement strategies in line with the evolving needs of patients. The conversation focused on driving patient access and adherence to novel therapies through digital engagement and real-time information.
The COVID-19 global health crisis has accelerated trends toward digital and remote solutions for patients. Adapting and integrating new digital solutions is critical to getting patients to start and continue novel therapies.
These new technology solutions extend to the ability to merge external data sources together with analytics from the patient support program for enhanced analysis. This is particularly important as we see more outcomes-driven reimbursement models. Technology is also enabling rare disease patients to find communities and support in a way that was not possible before.
To hear more about how to uncover ways to facilitate deeper connections between your brand and patients, listen to the full interview here.